Monitoring

Regularly monitor the following in hospitalised patients to facilitate early recognition of deterioration and monitor for complications:[2][822]

  • Vital signs (temperature, respiratory rate, heart rate, blood pressure, oxygen saturation)

  • Haematological and biochemistry parameters

  • Coagulation parameters (D-dimer, fibrinogen, platelet count, prothrombin time)

  • ECG

  • Chest imaging

  • Signs and symptoms of venous or arterial thromboembolism.

Medical early warning scores

  • Utilise medical early warning scores that facilitate early recognition and escalation of treatment of deteriorating patients (e.g., National Early Warning Score 2 [NEWS2], Paediatric Early Warning Signs [PEWS]) where possible.[2]

  • There are no data on the value of using these scores in patients with COVID-19 in the primary care setting.[852] 

Pregnant women

  • Monitor vital signs three to four times daily and fetal heart rate in pregnant women with confirmed infection who are symptomatic and admitted to hospital. Perform fetal growth ultrasounds and Doppler assessments to monitor for potential intrauterine growth restriction in pregnant women with confirmed infection who are asymptomatic.[536] Perform fetal growth ultrasound 14 days after resolution of symptoms.[538]

Use of this content is subject to our disclaimer